102
Views
3
CrossRef citations to date
0
Altmetric
Guidelines

Guidelines for aetiological investigation into mild to moderate bilateral permanent childhood hearing impairment

Produced by the British Association of Audiovestibular Physicians (BAAP) 2015

References

  • MacArdle B, Bitner-Glindzicz M. Investigation of the child with permanent hearing impairment. Arch Dis Child Educ Pract Ed. 2010;95:14–23. [Review]
  • British Association of Audiovestibular Physicians manual for Producing Guidelines, Clinical Standards Subcommittee BAAP, 2013. [Guideline]
  • Woolf S, Grol R, Hutchinson A, et al. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318:527–530.
  • Quality Standards in the NHS Newborn Hearing Screening Programme September 2010. [Quality Standard Document] Available from: http://hearing.screening.nhs.uk/standardsandprotocols#fileid10752.
  • Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323:334–336.
  • General Medical Council [2013] Good Medical Practice London GMC. Available from: http://www.gmc-uk.org/guidance/good_medical_practice.asp.
  • Hampton J, Harrison M, Mitchell J, et al. Relative contributions of history-taking, Physical examination, and laboratory investigation to diagnosis and management of medical outpatients. BMJ. 1975;2:486–489. [level 3]
  • Paley L, Zornitski T, Cohen J, et al. Utility of clinical examination in the diagnosis of emergency department patients admitted to the department of medicine of an academic hospital. Arch Intern Med. 2011;171:1393–1400. [level 3]
  • Yield of Investigations from the BAAP National Audit, 2013. Unpublished data, BAAP. [level 3]
  • Mafong D, Shin E, Lalwani A. Use of Laboratory evaluation and radiologic imaging in the diagnostic evaluation of children with sensorineural hearing loss. Laryngoscope. 2002;112:1–7. [Level 3]
  • Cone B, Wake M, Tobin S, et al. Slight-mild sensorineural hearing loss in children: audiometric, clinical, and risk factor profiles. Ear Hear. 2010;31:202–212. [Level 3]
  • Robertson C, Howarth T, Bork D, et al. Permanent bilateral sensory and neural hearing loss of children after neonatal intensive care because of extreme prematurity: a thirty-year study. Pediatrics. 2009;123:130. [level 2-].
  • De Jong T, Toll M, De Gier H, et al. Audiological profile of children and young adults with syndromic and complex craniosynostosis. Arch Otolaryngol Head Neck Surg. 2011;137:775–778.
  • Stephens D. Audiometric investigation of first-degree relatives. In: Martini A, Mazzoli M, Stephens D, Read A, editors. Definitions, protocols & guidelines in genetic hearing impairment. London: Whurr Publishers; 2001. p. 32–33.
  • Stephens D, Meredith R, Sirimanna T, et al. Application of the Audioscan in the detection of carriers of genetic hearing loss. Audiology. 1995;34:91–97. [Level 2-]
  • Declau F, Boudewyns A, Van den Ende J, et al. Etiologic and audiologic evaluations after universal neonatal hearing screening: analysis of 170 referred neonates. Pediatrics. 2008;121:1119–1126. [Level 2+]
  • Enders G, Daiminger A, Bäder U, et al. The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. J Clin Virol. 2013;56:102–107. [Level 2+]
  • Boppana S, Ross S, Shimamura M, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364: 2111–2118. [level 2+]
  • Boppana S, Ross S, Novak Z, et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 2010;303:1375–1382. [level 2+]
  • Barbi M, Binda S, Primache V, et al. Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol. 2000;17:159–165. [level 2+]
  • Williams E, Kadambari S, Berrington J, et al. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss. Arch Dis Child Fetal Neonatal Ed. 2014;99:F1–F7. [level 2+]
  • de Vries J, van der Eijk A, Wolthers K, et al. Real time PCR versus viral culture on urine as a gold standard in the diagnosis of congenital cytomegalovirus infection. J Clin Virol. 2012;53:167–170. [level 2-]
  • Atkinson C, Walter S, Sharland M, et al. Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J Med Virol. 2009;81:1394–1398. [level 2-]
  • Tagawa M, Tanaka H, Moriuchi M, et al. Retrospective diagnosis of congenital cytomegalovirus infection at a school for deaf by using preserved dried umbilical cord. J Paediatrics. 2009;155:749–751. [level 2-]
  • Clinical Virology Network Guidelines. Unpublished data. [Guideline]. Available from: http://www.clinicalvirology.org/guideliness
  • Lucassen A, Hall A. Consent and confidentiality in clinical genetic practice: guidance on genetic testing and sharing genetic information. A report of the Joint Committee. Clin Med (Lond). 2012;12:5–6.
  • Kenna M, Feldman H, Neault M, et al. Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. Arch Otolaryngol Head Neck Surg. 2010;136:81–87. [level 2+]
  • Ballana E, Ventayol M, Rabionet R, et al. Connexins and deafness Homepage [Internet] [cited 2016 Jul 10]. Available from: http://www.crg.es/deafness.
  • Denoyelle F, Weil D, Maw MA, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet. 1997;6: 2173–2177. [level 3]
  • Kessell D, Dunlop J, Lench N, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997;387:80–83.
  • Snoeckx R, Huygen P, Feldmann D, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet. 2005;77:945–957.
  • Cryns K, Orzan E, Murgia A, et al. A genotype phenotype correlation for GJB2 (connexin 26) deafness. J Med Genet. 2004;41:147–154.
  • Volo T, Leonardi E, Ghiselli S, et al. The effect of environmental risk factors on GJB2/Cx26 and GJB6/Cx30 hearing loss. Int J Pediatr Otorhinolaryngol. 2011;75:8.
  • Wilcox S, Saunders K, Osborn A, et al. High frequency hearing loss correlated with mutations in the GJB2 gene. Hum Genet. 2000;106:399–405. [Level 2+]
  • Wiley S, Arjmand E. Jareenmeinzen-Derr, et al. Findings from multidisciplinary evaluation of children with permanent hearing loss. Int J Pediatr Otorhinolaryngol. 2011;75:1040–1044.
  • Preciado D, Lawson L Madden C, et al. Improved diagnostic effectiveness with a sequential diagnostic paradigm in idiopathic pediatric sensorineural hearing loss. Otol Neurotol. 2005;26:610–615.
  • Shearer A, DeLuca A, Hildebrand M, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA. 2010;107:21104–21109. [level 3]
  • Hoefsloot L, Roux A, Bitner-Glindzicz M. EMQN Best Practice guidelines for diagnostic testing of mutations causing non-syndromic hearing impairment at the DFNB1 locus. Eur J Hum Genet. 2013;21:1325–1329.
  • Bamiou D, Phelps P, Sirimanna T. Temporal bone computed tomography findings in bilateral sensorineural hearing loss. Arch Dis Child 2000;82:257–260.
  • Lin J, Chowdhury N, Mody A, et al. Comprehensive diagnostic battery for evaluating sensorineural hearing loss in children. Otol Neurotol. 2011;32:259–264.
  • Licameli G, Kenna M. Is computerised tomography [CT] or magnetic resonance imaging [MRI] more useful in the evaluation of pediatric sensorineural hearing loss? Laryngoscope 2010;120:2358–2359.
  • Sennaroglu L, Saatci I, Aralasmak A, et al. Magnetic resonance imaging versus computed tomography in pre-operative evaluation of cochlear implant candidates with congenital hearing loss. J Laryngol Otol. 2002;116:804–810. [level 3]
  • Yang J, Li Y. Constitute, imaging and auditory characteristics of pediatric patients with congenital malformations of inner ear in sensorineural hearing loss. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;25:1–5.
  • McClay J, Booth T, Parry D, et al. Evaluation of pediatric sensorineural hearing loss with magnetic resonance imaging. Arch Otolaryngol Head Neck Surg. 2008;134:945–952.
  • Taiji H, Morimoto N, Matsunaga T. Unilateral cochlear nerve hypoplasia in children with mild to moderate hearing loss. Acta Otolaryngol. 2012;132: 1160–1167.
  • Nikolopoulos P, Lioumi D, Stamataki S, et al. Evidence-based overview of ophthalmic disorders in deaf children: a literature update. Otol Neurotol. 2006;27:S1–S24.
  • Johnstone D, Curry J, Newborough B, et al. Ophthalmologic disorders in children with syndromic and nonsyndromic hearing loss. Arch Otolaryngol Head Neck Surg. 2010;136:277–280.
  • Sharma A, Ruscetta M, Chi D. Ophthalmologic findings in children with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2009;135: 119–123.
  • Quality Standards in Vision Care for Deaf Children and Young People. Guidelines for professionals. [NDCS and SENSE 2009]. [Quality Standards Document]
  • Abadie C, Blanchet C, Baux D, et al. Audiological findings in 100 USH2 patients. Clin Genet. 2012;82:433–438.
  • Savige J, Gregory M, Gross O, et al. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013;24:364–375. [level 3]
  • Kashtan C, Ding J, Licht C. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol. 2013;28:5–11.
  • Raju P, Cimbaluk D, Corbet S. The variable course of women with X-linked Alport syndrome. Clin Kidney J. 2013;6:630–634.
  • Alves F, de A Quintanilha Ribeiro F. Revision about hearing loss in the Alport's syndrome, analyzing the clinical, genetic and bio-molecular aspects. Braz J Otorhinolaryngol. 2005;71:813–819.
  • Alves F, Ribeiro F. Clinical data and hearing of individuals with Alport syndrome. Braz J Otorhinolaryngol. 2008;74:807–814. [Level 3]
  • Brown E, Chau J, Atashband S, et al. A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J Pediatr Otorhinolaryngol. 2009;73:707–711.
  • de Jong E, Vossen A, Walther F. How to use neonatal TORCH testing. Arch Dis Child Educ Pract Ed. 2013;98:93–98.
  • Sánchez P, Wendel G, Norgard M. Congenital syphilis associated with negative results of maternal serologic tests at delivery. Am J Dis Child. 1991;145: 967–969.
  • Rawstron S, Mehta S, Bromberg K. Evaluation of a Treponema pallidum-specific IgM enzyme immunoassay and Treponema pallidum western blot antibody detection in the diagnosis of maternal and congenital syphilis. Sex Transm Dis. 2004;31:123–126.
  • Torre P, Zeldow B, Hoffman H, et al. Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents. Pediatric HIVAIDS Cohort Study. Pediatr Infect Dis J. 2012;31:835–841.
  • Palacios G, Montalvo M, Fraire M, et al. Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy. Int J Pediatr Otorhinolaryngol. 2008;72:1671–1681.
  • Santos S, Sgambatti L, Bueno A, et al. Enlarged vestibular aqueduct syndrome. Acta Otorrinolaringol Esp. 2010;61:338–344.
  • Lindau T, Cardoso A, Rossi N, et al. Anatomical changes and Audiological profile in Branchio-oto-renal syndrome: a literature review. Int Arch Otorhinolaryngol. 2014;18:68–76.
  • Morales Angulo C, Gallo-Terán J, Señaris B, et al. Prevalence of the A1555G MTDNA mutation in sporadic hearing-impaired patients without known history of aminoglycoside treatment. Acta Otorrinolaringol Esp. 2011;62:83–86.
  • Wang R, Earl D, Ruder RO, et al. Syndromic ear anomalies and renal ultrasounds. Pediatrics 2001;108:E32. [level 3]
  • Bogazzi F, Russo D, Raggi F, et al. Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct. J Endocrinol Invest. 2004;27:430–435. [level 2-]
  • Iwasaki S, Tsukamoto K, Usami S, et al. Association of SLC26A4 mutations with clinical features and thyroid function in deaf infants with enlarged vestibular aqueduct. J Hum Genet. 2006;51:805–810.
  • Reddy M, Satyanarayana V, Hemabindu L, et al. Immunological studies in children with hearing impairment. J Indian Med Assoc. 2005;103:520–521.
  • Agrup C, Luxon L. Immune-mediated inner-ear disorders in neuro-otology. Curr Opin Neurol. 2006;19:26–32.
  • Raglan E, Radomskij P, Veness J, et al. An audio-vestibular study of 128 children presenting to a specialised paediatric audio-vestibular clinic: should every child with hearing impairment have vestibular function assessed? Audiol Med. 2009;7:143–147.
  • De Kegel A, Maes L, Baetens T, et al. The influence of a vestibular dysfunction on the motor development of hearing-impaired children. Laryngoscope 2012;122:2837–2843.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.